Skip to content
healthcare.dev

Doxazosin

NDC 66267-377, Doxazosin, tablet, from NuCare Pharmaceuticals, Inc..

Product NDC
66267-377
Status
Listed
Labeler
NuCare Pharmaceuticals, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA202824
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/66267-377 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DOXAZOSIN MESYLATE4 mg/1

Pharmacologic classes

Adrenergic alpha-Antagonists [MoA]; alpha-Adrenergic Blocker [EPC]

Package NDCNDC-11Package
66267-377-306626703773030 TABLET in 1 BOTTLE (66267-377-30)
66267-377-906626703779090 TABLET in 1 BOTTLE (66267-377-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/40e47e75-6a47-323b-e054-00144ff8d46c

Use it

Look up 66267-377 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/66267-377 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 66267-377. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.